Author Details

Perepukhov, V. M.

Issue Section Title File
Vol 16, No 4 (2020) REVIEW Diferelin® as an effective chemical castration agent for patients with prostate cancer PDF
(Rus)
Vol 17, No 4 (2021) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER Nomograms for predicting the risk of biochemical recurrence in patients with prostate cancer after surgery PDF
(Rus)
Vol 17, No 3 (2021) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER Current capabilities in treatment of non-metastatic castration-resistant prostate cancer: effectiveness, safety, and quality of life of patients taking darolutamide PDF
(Rus)
Vol 18, No 3 (2022) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER Nomograms for predicting local recurrence in prostate cancer patients with a positive resection margin PDF
(Rus)
Vol 18, No 2 (2022) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice PDF
(Rus)
Vol 19, No 4 (2023) REVIEWS Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer PDF
(Rus)
Vol 20, No 3 (2024) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness PDF
(Rus)
Vol 20, No 3 (2024) DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER Androgen deprivation therapy and cardiological risks in patients with prostate cancer. Are all drugs the same? PDF
(Rus) PDF
(Eng)
Vol 21, No 2 (2025) REVIEWS Review of the effectiveness of nuclear magnetic resonance spectroscopy for prostate cancer diagnosis PDF
(Rus)
Vol 20, No 4 (2024) TOPICAL PROBLEM Modern approaches to treatment of castration-resistant prostate cancer using targeted radionuclide therapy in patients with bone metastases PDF
(Rus)